Close Menu

Anthony Fauci, director of the US National Institute of Allergy and Infectious Diseases, announced last week that a clinical trial indicated that COVID-19 patients who receive remdesivir recover more quickly from the disease than those who did not receive the drug, Nature News reports. It notes, however, that another trial reported at the same time that there was no benefit from the drug.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Science reports that a new White House Office of Management and Budget memo rescinds previous ones that helped research institutions deal with pandemic-related closures.

Researchers report on a concerning strain of the H1N1 swine flu virus found among pigs in China, Agence France Presse reports.

The Associated Press reports that US officials are considering allowing pooled COVID-19 testing.

In Genome Research this week: Y chromosome gene expression analysis, de novo mutations rise with paternal age in rhesus macaques, and more.